Gupta VK, Giri R, Agrawal S. Dipeptidyl peptidase-4 inhibitor (teneligliptin) significantly reduces liver fat content and delays progression of non-alcoholic steatohepatitis in type 2 diabetes mellitus patients. Int J Adv Med [Internet]. 2021 Nov. 23 [cited 2025 Oct. 13];8(12):1817-20. Available from: https://www.ijmedicine.com/index.php/ijam/article/view/3257